investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Targeting to Epigenetic Modications in ALL
Scott A Armstrong
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Scott A Armstrong
Memorial Sloan Kettering Cancer Center
New York, United States
Related projects
Hiroaki Mitsuya
Development of Novel Agents Active against Hepatitis B Virus
Leukaemia
Pathology
Honami Naora
Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes
Leukaemia
Catherine Ju-Ying Wu
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
Leukaemia
James Kochenderfer
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
Leukaemia
Hematology and hematologic malignancies
Robert G Roeder
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
Leukaemia
David A Scheinberg
Mechanisms of action of a TCR-like antibody to WT1
Leukaemia
Clark W Distelhorst
Targeting PKM2-InsP3R interaction to treat AML
Leukaemia
Hematology and hematologic malignancies
Joseph H Antin
A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT
Leukaemia
David A Williams
Rac proteins in hematopoietic cell survival and function
Leukaemia
Hematology and hematologic malignancies